BeStock  
Stocks › Medical Devices › SIBN

Si-Bone SIBN

US equityMarket cap rank #3350Medical Devices
$19.10 −$0.45 (-2.30%)
Market closed · Oct 8, 4:10 am ET · Last extended-hours $19.10 0.00%
Open$19.27
Prev close$19.55
Day range$18.98 – $19.69
Volume547.6K
Market cap$856.03M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$56.01M+15.2% YoY
Operating profit-$4.81M+31.4% YoY
Net profit-$4.09M+33.6% YoY
Diluted EPS-$0.09+35.7% YoY
Free cash flow-$768,000.00+60.1% YoY
Operating cash flow$777,000.00

Revenue, last 8 quarters

$40.3MSep '24$49.0MDec '24$47.3MMar '25$48.6MJun '25$48.7MSep '25$56.3MDec '25$52.6MMar '26$56.0MJun '26

Net profit, last 8 quarters

$-6.6MSep '24$-4.5MDec '24$-6.5MMar '25$-6.2MJun '25$-4.6MSep '25$-1.6MDec '25$-4.3MMar '26$-4.1MJun '26

Diluted EPS by quarter

-0.16Sep '24-0.11Dec '24-0.15Mar '25-0.14Jun '25-0.11Sep '25-0.04Dec '25-0.10Mar '26-0.09Jun '26

Free cash flow by quarter

$-2.7MSep '24$-1.1MDec '24$-7.0MMar '25$-1.9MJun '25$-620.0KSep '25$440.0KDec '25$-3.4MMar '26$-768.0KJun '26

Annual revenue

$73.4MFY20$90.2MFY21$106.4MFY22$138.9MFY23$167.2MFY24$200.9MFY25

Profitability & balance sheet

Gross margin79.5%
Operating margin-8.3%
Net margin-6.9%
Return on equity-8.3%
Return on assets-6.1%
Return on invested capital-8.2%
Current ratio9.15
Liabilities / assets26.7%
Cash & investments$145.94M
Total debt$42.37M
Net cash (debt)$103.57M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $56.01M $52.59M $200.93M $56.35M $48.66M
Total Operating Revenue $56.01M $52.59M $200.93M $56.35M $48.66M
Cost of Revenue $11.46M $10.64M $41.05M $11.82M $9.81M
Gross Profit $44.55M $41.94M $159.88M $44.53M $38.85M
Operating Expense $49.35M $47.04M $182.21M $46.99M $44.23M
Selling and Admin Expenses $44.13M $42.85M $164.76M $42.63M $39.99M
-Selling & Marketing Expense $34.02M $32.81M $124.22M $32.81M $29.96M
-General & Admin Expense $10.11M $10.04M $40.54M $9.83M $10.03M
Research & Development $5.22M $4.19M $17.45M $4.36M $4.24M
Operating Profit -$4.81M -$5.09M -$22.33M -$2.46M -$5.38M
Net Non-Operating Interest Income (Expense) $734,000.00 $758,000.00 $3.45M $817,000.00 $845,000.00
Non-Operating Interest Income $1.33M $1.35M $6.07M $1.45M $1.52M
Non-Operating Interest Expense $598,000.00 $592,000.00 $2.63M $630,000.00 $670,000.00
Other Income (Expense) -$16,000.00 $1,000.00 -$20,000.00 $2,000.00 -$28,000.00
Other Non-Operating Income (Expenses) -$16,000.00 $1,000.00 -$20,000.00 $2,000.00 -$28,000.00
Pretax Profit -$4.09M -$4.33M -$18.90M -$1.64M -$4.57M
Net Profit -$4.09M -$4.33M -$18.90M -$1.64M -$4.57M
Profit from Continuing Operations -$4.09M -$4.33M -$18.90M -$1.64M -$4.57M
Net Income to Parent Company -$4.09M -$4.33M -$18.90M -$1.64M -$4.57M
Net Income to Common Stockholders -$4.09M -$4.33M -$18.90M -$1.64M -$4.57M
Basic EPS -$0.09 -$0.10 -$0.44 -$0.04 -$0.11
Diluted EPS -$0.09 -$0.10 -$0.44 -$0.04 -$0.11

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $248.76M $242.72M $238.56M $238.56M $234.27M
Total Current Assets $219.91M $214.72M $216.12M $216.12M $210.78M
Cash and Cash Equivalents & Short-Term Investments $145.94M $144.68M $147.82M $147.82M $145.74M
-Cash and Cash Equivalents $33.13M $33.54M $42.24M $42.24M $26.49M
-Short Term Investments $112.81M $111.15M $105.58M $105.58M $119.26M
Receivables $31.18M $31.56M $29.92M $29.92M $26.53M
-Accounts Receivable $31.18M $30.96M $29.92M $29.92M $26.53M
Inventory $38.39M $35.53M $33.90M $33.90M $35.73M
Other Current Assets $4.40M $2.94M $4.48M $4.48M $2.78M
Total Non-Current Assets $28.85M $28.00M $22.44M $22.44M $23.49M
Net PPE $28.63M $27.78M $22.39M $22.39M $23.18M
-Gross PPE $54.28M $51.91M $44.93M $44.93M $46.98M
-Accumulated Depreciation -$25.65M -$24.13M -$22.55M -$22.55M -$23.80M
Other Non-Current Assets $216,000.00 $217,000.00 $55,000.00 $55,000.00 $306,000.00
Total Liabilities $66.41M $63.78M $61.02M $61.02M $62.15M
Total Current Liabilities $24.04M $21.49M $25.28M $25.28M $26.44M
Payables $8.54M $6.76M $4.63M $4.63M $7.72M
-Accounts Payable $8.54M $6.76M $4.63M $4.63M $7.72M
Current Accrued Expenses $4.56M $5.00M $4.92M $4.92M $4.27M
Short-Term Debt and Capital Lease Obligation $426,000.00 $658,000.00 $944,000.00 $944,000.00 $1.13M
-Current Capital Lease Obligation $426,000.00 $658,000.00 $944,000.00 $944,000.00 $1.13M
Other Current Liabilities $889,000.00 $1.01M $879,000.00 $879,000.00 $926,000.00
Total Non-Current Liabilities $42.37M $42.29M $35.74M $35.74M $35.71M
Long Term Debt and Capital Lease Obligation $42.37M $42.29M $35.74M $35.74M $35.71M
-Long Term Debt $35.63M $35.60M $35.57M $35.57M $35.54M
-Long Term Capital Lease Obligation $6.74M $6.69M $175,000.00 $175,000.00 $165,000.00
Total Equity $182.35M $178.94M $177.53M $177.53M $172.13M
Stockholders' Equity $182.35M $178.94M $177.53M $177.53M $172.13M
Capital Stock $4,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00
-Common Stock $4,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $640.64M $633.03M $626.97M $626.97M $619.96M
Retained Earnings -$458.68M -$454.59M -$450.26M -$450.26M -$448.61M
Gains/Losses Not Affecting Retained Earnings $387,000.00 $501,000.00 $816,000.00 $816,000.00 $772,000.00
-Accrued Interest Receivable – $600,000.00 – – –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $777,000.00 -$2.36M -$675,000.00 $1.73M $2.34M
Net cash flow from continuing operations $777,000.00 -$2.36M -$675,000.00 $1.73M $2.34M
Net Income from Continuing Operations -$4.09M -$4.33M -$18.90M -$1.64M -$4.57M
Gain/Loss from Continuing Operations $254,000.00 $332,000.00 $1.63M $185,000.00 $814,000.00
Depreciation & Depletion & Amortization $1.68M $1.62M $5.77M $1.64M $1.49M
Other Non-Cash Items -$60,000.00 $119,000.00 $687,000.00 $62,000.00 $566,000.00
Change in Working Capital -$2.60M -$5.95M -$14.33M -$4.09M -$1.57M
-Change in Receivables -$300,000.00 -$1.14M -$3.03M -$3.39M -$2.23M
-Change in Inventory -$2.81M -$2.04M -$8.68M $1.65M -$2.04M
-Change in Prepaid Assets -$860,000.00 $777,000.00 -$1.03M -$1.45M $512,000.00
-Change in Payables and Accrued Expense $1.37M -$3.54M -$1.58M -$902,000.00 $2.20M
Net cash flow from investing -$2.74M -$6.23M $4.16M $13.03M -$10.03M
Net Cash Flow from Continuing Investing Activities -$2.74M -$6.23M $4.16M $13.03M -$10.03M
Net PPE Purchase and Sale -$1.55M -$1.08M -$8.41M -$1.29M -$2.96M
Net Investment Purchase and Sale -$1.19M -$5.16M $12.57M $14.31M -$7.07M
Financing Cash Flow $1.63M $34,000.00 $3.38M $1.03M $11,000.00
Net Cash Flow from Continuing Financing Activities $1.63M $34,000.00 $3.38M $1.03M $11,000.00
Proceeds from Stock Option Exercised $1.63M $34,000.00 $3.38M $1.03M $11,000.00
Ending Cash Balance $33.13M $33.54M $42.24M $42.24M $26.49M
Net Change in Cash -$333,000.00 -$8.56M $6.86M $15.78M -$7.68M
Beginning Cash Balance $33.54M $42.24M $34.95M $26.49M $34.15M
Effect of Exchange Rate Changes -$74,000.00 -$145,000.00 $431,000.00 -$30,000.00 $16,000.00
Free Cash Flow -$768,000.00 -$3.44M -$9.09M $440,000.00 -$620,000.00
Net Issuance Payments Of Debt – – $0.00 – –
Net Common Stock Issuance – – $0.00 – –

Discussion

No comments yet — be the first to weigh in on SIBN.

Leave a comment

Scroll to Top